Caleium Pharm:Ph3 CAEL-101-301 AL Amyloidosis

Clinical Trial Grant

Duke Scholars

Principal Investigator Cristiana A. Costa Medicine, Hematologic Malignancies and Cellular Therapy

Administered By

Duke Cancer Institute

Awarded By

Caelum BioSciences, Inc

Start Date

June 16, 2021

End Date

June 30, 2026

Administered By

Duke Cancer Institute

Awarded By

Caelum BioSciences, Inc

Start Date

June 16, 2021

End Date

June 30, 2026